Recent advances of smart materials for ocular drug delivery

Adv Drug Deliv Rev. 2023 Sep:200:115006. doi: 10.1016/j.addr.2023.115006. Epub 2023 Jul 13.

Abstract

Owing to the variety and complexity of ocular diseases and the natural ocular barriers, drug therapy for ocular diseases has significant limitations, such as poor drug targeting to the site of the disease, poor drug penetration, and short drug retention time in the vitreous body. With the development of biotechnology, biomedical materials have reached the "smart" stage. To date, despite their inability to overcome all the aforementioned drawbacks, a variety of smart materials have been widely tested to treat various ocular diseases. This review analyses the most recent developments in multiple smart materials (inorganic particles, polymeric particles, lipid-based particles, hydrogels, and devices) to treat common ocular diseases and discusses the future directions and perspectives regarding clinical translation issues. This review can help researchers rationally design more smart materials for specific ocular applications.

Keywords: Drug delivery; Ocular diseases; Smart materials.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials*
  • Drug Delivery Systems*
  • Humans
  • Pharmaceutical Preparations
  • Polymers

Substances

  • Biocompatible Materials
  • Polymers
  • Pharmaceutical Preparations